PACS Group (NYSE:PACS – Get Free Report) is projected to post its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect the company to post earnings of $0.5790 per share and revenue of $1.46 billion for the quarter. Parties may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 11:30 AM ET.
PACS Group (NYSE:PACS – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.09. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. On average, analysts expect PACS Group to post $2.13 EPS for the current fiscal year and $2.57 EPS for the next fiscal year.
PACS Group Trading Down 0.1%
Shares of PACS opened at $47.76 on Monday. PACS Group has a fifty-two week low of $10.31 and a fifty-two week high of $50.38. The company has a market capitalization of $7.56 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 1.49 and a beta of -0.14. The stock has a fifty day moving average of $44.21 and a two-hundred day moving average of $39.79. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on the stock. Zacks Research lowered shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Weiss Ratings raised shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Oppenheimer lifted their price target on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, Truist Financial set a $62.00 target price on shares of PACS Group in a research note on Wednesday, September 2nd. Five investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $58.80.
Read Our Latest Analysis on PACS Group
Insiders Place Their Bets
In other news, CEO Jason Murray sold 1,904 shares of the business’s stock in a transaction that occurred on Thursday, October 29th. The stock was sold at an average price of $50.05, for a total value of $95,295.20. Following the transaction, the chief executive officer directly owned 54,179,397 shares of the company’s stock, valued at $2,711,678,819.85. The trade was a 0.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle Lewis sold 2,364 shares of PACS Group stock in a transaction on Thursday, October 29th. The shares were sold at an average price of $50.04, for a total value of $118,294.56. Following the completion of the sale, the chief accounting officer directly owned 343,510 shares of the company’s stock, valued at $17,189,240.40. This trade represents a 0.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,347,267 shares of company stock valued at $60,021,034. 70.10% of the stock is currently owned by insiders.
About PACS Group
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Featured Stories
- Five stocks we like better than PACS Group
- Uranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
